RIOT, WIX among premarket gainers

Applied DNA Sciences (APDN) +71% after receiving FDA emergency use authorization for COVID-19 test.AIM ImmunoTech (AIM) +31% on Q1 results.Immunic (IMUX) +22% on launch study of IMU-838 in COVID-19.Allogene Therapeutics (ALLO) +16% on reporting initial ALLO-501 phase 1 trial data.Co-Diagnostics (CODX) +14% as disappointing sensitivity data from a New York study evaluating Abbott's ID Now rapid molecular test for SARS-CoV-2.Verona Pharma plc (VRNA) +13% on FDA response to end-of-phase 2 briefing package for Ensifentrine in COPD and outlines phase 3 enhance clinical program.Futu Holdings (FUTU) +10% on Q1 results.Altimmune (ALT) +9% on Q1 results.Pluristem Therapeutics (PSTI) +9% on updating 28-day follow up for ventilator-dependent COVID-19 patients.Summit Wireless Technologies (WISA) +8% as Broomx joins.Riot Blockchain (RIOT) +7%.Wix.com (WIX) +7% on Q1 results.Predictive Oncology (POAI) +6% on licensing and partnering this groundbreaking NSP10 technology in the race to develop a vaccine for development.Aytu BioScience (AYTU) +5%.NanoViricides (NNVC) +5%.